Skip to main content

Margarita Navarro Pérez

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Margarita Navarro Pérez

Margarita Navarro Pérez

Margarita Navarro Pérez

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Related professionals

Débora Ferrate Navarro

Débora Ferrate Navarro

Gestió i Administració
Purchase and Biddings Unit
Finance Directorate
Read more
Verónica Villagrasa Araya

Verónica Villagrasa Araya

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
David Espejo Castellanos

David Espejo Castellanos

Predoctoral researcher
Pneumology
Read more
Pau Bravo Aubeso

Pau Bravo Aubeso

Tècnic de recerca
Technological Infrastructure Unit
Digital Transformation Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.